Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification
Emilie Barruet, … , Mary C. Nakamura, Edward C. Hsiao
Emilie Barruet, … , Mary C. Nakamura, Edward C. Hsiao
Published November 15, 2018
Citation Information: JCI Insight. 2018;3(22):e122958. https://doi.org/10.1172/jci.insight.122958.
View: Text | PDF
Clinical Research and Public Health Bone biology Inflammation

NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification

  • Text
  • PDF
Abstract

BACKGROUND. Inflammation helps regulate normal growth and tissue repair. Although bone morphogenetic proteins (BMPs) and inflammation are known contributors to abnormal bone formation, how these pathways interact in ossification remains unclear. METHODS. We examined this potential link in patients with fibrodysplasia ossificans progressiva (FOP), a genetic condition of progressive heterotopic ossification caused by activating mutations in the Activin A type I receptor (ACVR1/ALK2). FOP patients show exquisite sensitivity to trauma, suggesting that BMP pathway activation may alter immune responses. We studied primary blood, monocyte, and macrophage samples from control and FOP subjects using multiplex cytokine, gene expression, and protein analyses; examined CD14+ primary monocyte and macrophage responses to TLR ligands; and assayed BMP, TGF-β activated kinase 1 (TAK1), and NF-κB pathways. RESULTS. FOP subjects at baseline without clinically evident heterotopic ossification showed increased serum IL-3, IL-7, IL-8, and IL-10. CD14+ primary monocytes treated with the TLR4 activator LPS showed increased CCL5, CCR7, and CXCL10; abnormal cytokine/chemokine secretion; and prolonged activation of the NF-κB pathway. FOP macrophages derived from primary monocytes also showed abnormal cytokine/chemokine secretion, increased TGF-β production, and p38MAPK activation. Surprisingly, SMAD phosphorylation was not significantly changed in the FOP monocytes/macrophages. CONCLUSIONS. Abnormal ACVR1 activity causes a proinflammatory state via increased NF-κB and p38MAPK activity. Similar changes may contribute to other types of heterotopic ossification, such as in scleroderma and dermatomyositis; after trauma; or with recombinant BMP-induced bone fusion. Our findings suggest that chronic antiinflammatory treatment may be useful for heterotopic ossification.

Authors

Emilie Barruet, Blanca M. Morales, Corey J. Cain, Amy N. Ton, Kelly L. Wentworth, Tea V. Chan, Tania A. Moody, Mariëlle C. Haks, Tom H.M. Ottenhoff, Judith Hellman, Mary C. Nakamura, Edward C. Hsiao

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2009 Total
Citations: 8 15 7 13 12 4 4 1 64
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2024 (15)

Title and authors Publication Year
Abnormal TGF-β signaling activation by intrinsic BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva
Chengzhu Zhao, Yoshiko Inada, Souta Motoike, Daisuke Kamiya, Kyosuke Hino, Makoto Ikeya
EMBO molecular medicine 2024
The Role of Neuromodulation and Potential Mechanism in Regulating Heterotopic Ossification.
Li D, Liu C, Wang H, Li Y, Wang Y, An S, Sun S
Neurochemical Research 2024
Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance.
Liu F, Zhao Y, Pei Y, Lian F, Lin H
Cell communication and signaling : CCS 2024
Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification
Juan C, Bancroft AC, Choi JH, Nunez JH, Pagani CA, Lin YS, Hsiao EC, Levi B
Biomolecules 2024
Immunologic Aspects in Fibrodysplasia Ossificans Progressiva
Diolintzi A, Pervin MS, Hsiao EC
Biomolecules 2024
Calcified apoptotic vesicles from PROCR+ fibroblasts initiate heterotopic ossification
Yan J, Gao B, Wang C, Lu W, Qin W, Han X, Liu Y, Li T, Guo Z, Ye T, Wan Q, Xu H, Kang J, Lu N, Gao C, Qin Z, Yang C, Zheng J, Shen P, Niu L, Zou W, Jiao K
Journal of Extracellular Vesicles 2024
Cell Senescence in Heterotopic Ossification
Pignolo RJ, Kaplan FS, Wang H
Biomolecules 2024
Metformin alleviates genetic and traumatic heterotopic ossification by inhibiting infiltration and mitochondrial metabolism of myeloid cells
Fan H, Cheng Q, Lin K, Gong L, Kan C, Wang S, Zheng H
American journal of translational research 2024
Ilizarov technique for treating elbow stiffness caused by myositis ossificans: A case report
Zhou MW, Zhang PW, Zhang AL, Wei CH, Xu YD, Chen W, Fu ZB
World journal of clinical cases 2024
Estrogen Deficiency Exacerbates Traumatic Heterotopic Ossification in Mice
Wang Z, Wu Y, Yi W, Yu Y, Fang X, Li Z, Yu A
Journal of Inflammation Research 2024
Long-term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva
Haviv R, Zeitlin L, Moshe V, Ziv A, Rabinowicz N, De Benedetti F, Prencipe G, Matteo V, De Cunto CL, Hsiao EC, Uziel Y
Rheumatology (Oxford, England) 2024
Role of hedgehog signaling in the pathogenesis and therapy of heterotopic ossification.
Pei Y, Liu F, Zhao Y, Lin H, Huang X
Frontiers in cell and developmental biology 2024
Challenges in tendon–bone healing: emphasizing inflammatory modulation mechanisms and treatment
Jiang F, Zhao H, Zhang P, Bi Y, Zhang H, Sun S, Yao Y, Zhu X, Yang F, Liu Y, Xu S, Yu T, Xiao X
Frontiers in Endocrinology 2024
Palovarotene (Sohonos), a synthetic retinoid for reducing new heterotopic ossification in fibrodysplasia ossificans progressiva: history, present, and future
Hsiao EC, Pacifici M
JBMR Plus 2024
Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice
Lounev V, Groppe JC, Brewer N, Wentworth KL, Smith V, Xu M, Schomburg L, Bhargava P, Al Mukaddam M, Hsiao EC, Shore EM, Pignolo RJ, Kaplan FS
Journal of Bone and Mineral Research 2024

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts